Return On Equity
59%
Trailing 12 months · Through 30 Jun 2026
YoY relative change: -136%
Period Q2 2026 · Filed 13 Aug 2026
Return On Equity
59%
Trailing 12 months · Through 30 Jun 2026
YoY relative change: -136%
Operating Margin
0%
Third-party reference; reporting period not verified
| Metric | Latest value | YoY relative change |
|---|---|---|
| Return On Equity |
59%
Trailing 12 months · 30 Jun 2026
|
-136% |
| Operating Margin |
0%
Third-party reference; reporting period not verified
|
| Metric | Latest value | YoY relative change |
|---|---|---|
| Net Income (Loss) Attributable to Parent |
$46,706
Trailing 12 months · 30 Jun 2026
|
| Metric | Latest value | YoY relative change |
|---|---|---|
| Entity Common Stock, Shares Outstanding |
18,348,330
Period-end balance · 12 Aug 2026
|
+84% |
| Common Stock, Shares, Outstanding |
9,948,330
Period-end balance · 30 Jun 2026
|
0% |
| Common Stock, Value, Issued |
$995
Period-end balance · 30 Jun 2026
|
0% |
| Weighted Average Number of Shares Outstanding, Diluted |
9,948,330
Reported period · 30 Jun 2026
|
0% |
These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.
| Metric | Latest value | YoY relative change |
|---|---|---|
| Additional Paid in Capital |
$154,600
Period-end balance · 30 Jun 2026
|
+269% |
| Assets |
$0
Period-end balance · 30 Jun 2026
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$0
Period-end balance · 30 Jun 2026
|
|
| Common Stock, Par or Stated Value Per Share |
0.0001
Period-end balance · 30 Jun 2026
|
0% |
| Common Stock, Shares Authorized |
100,000,000
Period-end balance · 30 Jun 2026
|
0% |
| Common Stock, Shares, Issued |
9,948,330
Period-end balance · 30 Jun 2026
|
0% |
| Earnings Per Share, Diluted |
0.01
Trailing 12 months · 30 Jun 2026
|
0% |
| General and Administrative Expense |
$33,561
Trailing 12 months · 30 Jun 2026
|
-11% |
| Liabilities |
$5,087
Period-end balance · 30 Jun 2026
|
-97% |
| Liabilities and Equity |
$0
Period-end balance · 30 Jun 2026
|
|
| Liabilities, Current |
$5,087
Period-end balance · 30 Jun 2026
|
-93% |
| Operating Income (Loss) |
$33,561
Trailing 12 months · 30 Jun 2026
|
+8.9% |
| Retained Earnings (Accumulated Deficit) |
$160,682
Period-end balance · 30 Jun 2026
|
+23% |
| Stockholders' Equity Attributable to Parent |
$5,087
Period-end balance · 30 Jun 2026
|
-103% |
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.
Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.
Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.
Latest update
Latest financial period: Q2 2026. Reopen this facts page to verify the newest reported period against the prior baseline.
Update date
13 Aug 2026
Page type
Company facts
Latest period
Q2 2026
SEC-backed company facts were refreshed from filings filed on 13 Aug 2026.
Benchmark Context
Return On Equity is down about 136% versus the comparable prior period.
Compared with
Compared with Stark Focus Group, Inc.'s recent history first. Same-industry peer context appears only when enough SEC-backed benchmark coverage exists.
Why this is notable
Return On Equity already has a self-history signal here, but same-industry benchmark context waits until the benchmark sample is strong enough.
Industry benchmark context uses SEC-reported values from the same methodology version. Latest periods may differ across companies.
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.
Latest financial snapshot (2026-08-12) highlights Return On Equity 58.6% and Operating Margin 0.0%.
SEC-only DCF estimate using a normalized free cash flow base, cash, debt, and reported share count when available.
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
75.0/100
Balanced Confidence low
59%
Metric score 100.0/100
Return On Equity
Operating Margin
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
CIK / security context first